NervGen Pharma Corp is actively recruiting for a landmark Phase 1b/2a proof-of-concept clinical trial of NVG-291 in individuals with spinal cord injury at the Shirley Ryan AbilityLab in Chicago. Some of the eligibility requirements for this trial include: ▶Age 18-75 ▶ Cervical SCI resulting from acute physical trauma ▶ Neurological level of injury C7 or higher ▶ Time since injury: either i) 1-10 years (chronic cohort 1) or ii) 10-49 days (subacute cohort 2) ▶ Must have some minimal function in h
0:11
NervGen Pharma Corp is actively recruiting for a landmark Phase 1b/2a proof-of-concept clinical trial of NVG-291 in individuals with spinal cord injury at the Shirley Ryan AbilityLab in Chicago. Some of the eligibility requirements for this trial include: ▶Age 18-75 ▶ Cervical SCI resulting from acute physical trauma ▶ Neurological level of injury C7 or higher ▶ Time since injury: either i) 1-10 years (chronic cohort 1) or ii) 10-49 days (subacute cohort 2) ▶ Must have some minimal function in h
525 viewsFeb 1, 2024
FacebookNew Mobility
NervGen Pharma Announces Expanded CONNECT SCI Study Data Demonstrating Unprecedented Durable Improvement in Function, Independence, and Quality of Life in Chronic Spinal Cord Injury
NervGen Pharma Announces Expanded CONNECT SCI Study Data Demonstrating Unprecedented Durable Improvement in Function, Independence, and Quality of Life in Chronic Spinal Cord Injury
5 months ago
newsfilecorp.com
NervGen Pharma Announces Expanded CONNECT SCI Study Data Demonstrating Unprecedented Durable Improvement in Function, Independence, and Quality of Life in Chronic Spinal Cord Injury
NervGen Pharma Announces Expanded CONNECT SCI Study Data Demonstrating Unprecedented Durable Improvement in Function, Independence, and Quality of Life in Chronic Spinal Cord Injury
5 months ago
investingnews.com
NervGen's NVG-291: a new hope for SCI recovery | NervGen Pharma Corp. posted on the topic | LinkedIn
0:38
NervGen's NVG-291: a new hope for SCI recovery | NervGen Pharma Corp. posted on the topic | LinkedIn
11 months ago
linkedin.com
NervGen NVG-291 Full Trial results for Spinal cord Injury #spinalcordinjury #science #research
2:10
NervGen NVG-291 Full Trial results for Spinal cord Injury #spinalcordinjury #science #research
336 views1 month ago
YouTubeBeyond Paralysis
Clinical Research Advancements in Spinal Cord Injury (SCI)
55:12
Clinical Research Advancements in Spinal Cord Injury (SCI)
595 viewsSep 13, 2024
VimeoNervGen Pharma Corp.
Can the Spinal Cord Repair Itself? The Historic NervGen Trial Results
4:07
Can the Spinal Cord Repair Itself? The Historic NervGen Trial Results
1.2K views5 months ago
YouTubeBeyond Paralysis
9:42
NervGen NVG-291: The Truth About the "Cure" for Spinal Cord Injury
1.9K views3 months ago
YouTubeBeyond Paralysis
8:37
Nervgen Pharma and NVG-291
2.3K views1 year ago
YouTubeLarry the SCI guy
2:51
NervGen NVG-291 The Truth About the "Cure" for Spinal Cord Injury #spinalcordinjury
885 views3 months ago
YouTubeBeyond Paralysis
NervGen Pharma pubblica i risultati finanziari dell'esercizio 2025 e fornisce aggiornamenti sulle attività
1 month ago
marketscreener.com
2:37
Can the Spinal Cord Repair Itself - with NVG-291 ... SPINAL CORD INJURY RESEARCH #clinicaltrials
1.3K views5 months ago
YouTubeBeyond Paralysis
NervGen Pharma to Ring the Nasdaq Closing Bell on January 22, 2026, Celebrating Its Recent Nasdaq Listing
3 months ago
marketscreener.com
13:46
Breakthrough spinal injury drug shows promise
6 months ago
fox32chicago.com
30:37
NervGen Pharma: A transformational technology following nerve damage due to disease and injury?
5K viewsJan 29, 2023
YouTubeANALITIKA GROUP
0:43
Ano pang inaantay niyo visit niyo na ang Champion Biotech & Pharma Corp., legit distributors ng #Owgels #OwgelsPhilippinesOfficial #OwgelsOxygenConcentrator #ChampionBiotechAndPharmaCorp | Jkhriez Pastrana
11.6K viewsJul 15, 2024
FacebookJkhriez Pastrana
19:53
مقابلة مع الدكتور آدم روجرز الرئيس التنفيذي لشركة نيرفجين فارما
178 views6 months ago
YouTubeوبشر الصابرين
Contract Manufacturing｜NIPRO PHARMA CORPORATION
Jun 3, 2016
nipro-pharma.co.jp
11:22
Spinal cord injury and regeneration - nerve repair: regeneration in spinal-cord injury
5.8K viewsSep 20, 2019
YouTubeHPR
14:33
825% Hand Improvement? NervGen NVG-291 SCI Final Results Are In. Plus Phase 3 Trial Announced!
1.2K views1 month ago
YouTubeBeyond Paralysis
Sumitomo Corporation in Asia Oceania
3 months ago
sumitomocorp.com
0:25
NervGen Pharma on Instagram: "Our lead drug candidate, NVG-291, that’s currently in clinical trials, has the groundbreaking potential to treat nervous system damage caused by injury or disease. 📣🎬🎥🎞 Check out the full video by Oscar® nominated social impact filmmaker, @dougroland, by clicking the link in our bio."
1.8K viewsDec 12, 2023
Instagramnervgen_pharma
0:05
نخستین داروی تایید شده در ضایعات نخاع؟!
10 views6 months ago
YouTubeدکتر سلمان فاطمی متخصص بیماری های مغز و اعصاب
25:50
MS and possible nerve regeneration? NVG-291 might be what we've been waiting for....
1.4K views4 months ago
YouTubeYou and Me and Multiple Sclerosis
1:01
Dr. Adam Rogers, MD - CEO, NervGen Pharma - Innovative Treatments For #NervousSystemRepair
666 views7 months ago
YouTubeProgress, Potential, and Possibilities
30:21
Dr. Adam Rogers, MD - CEO, NervGen Pharma - Innovative Treatments For Nervous System Repair
3K views7 months ago
YouTubeProgress, Potential, and Possibilities
8:40
NervGen Pharma Corp
2.3K viewsApr 23, 2025
VimeoNervGen Pharma Corp.
10:21
NervGen Pharma Corp - 2025 SCI Investor Symposium - Clinical Company Presentations
968 views10 months ago
YouTubeAnnual SCI Investor Symposium
12:24
NVG-291 Explained by Neurologist
18.8K viewsOct 30, 2024
YouTubeDr. Brandon Beaber
7:30
NervGen Pharma
8.3K viewsNov 18, 2023
VimeoNervGen Pharma Corp.
See more